Decoding ASXL3: A Novel Biomarker for Neurodevelopmental Disorders
ISEF · 2024 Cellular and Molecular Biology First Award
Overview
In a recent study, 33% of individuals with neurodevelopmental disorders (NDDs) carried mutations in ASXL3, whose function is unknown. To understand ASXL3’s role in NDDs, we used CRISPR technology to engineer three H9 embryonic stem-cell lines with varying doses ASXL3 levels: wild-type (ASXL3 +/+), heterozygous (ASXL3 +/-), and homozygous knockout (ASXL3 -/-). PCR and DNA sequencing confirmed that CRISPR-CAS9 generated the intended cell lines. Using these newly engineered cell lines, we generated rosettes and organoids to track cell growth and characterize cell differentiation through imaging and RNA sequencing analysis. The ASXL3 -/- cell lines exhibited accelerated growth compared to ASXL3-/+ or ASXL3 +/+. Furthermore, ASXL3 -/- organoids had an increased percentage of proliferative cells, evidenced by increased number of Ki67 cells, leading to an increase of neural progenitor cells. However, ASXL3 -/- organoids had reduced neuronal differentiation and less layer 5 cortical neurons, characterized by fewer BCL11B cells. This revealed the novel function of ASXL3 as a neural cell gate control. Additionally, the less layer 5 neurons impair the layer 5 functions of communication and fine motor skills, which generates the phenotype of the NDD, showing that ASXL3 -/- is a novel biomarker for NDDs. This pattern of increased proliferation and reduced differentiation was independently verified by differential RNA sequencing analysis between ASXL3 +/+ and ASXL3 -/-. Finally, to rescue the defects observed in ASXL3 -/- cells, we treated them with fibroblast growth factors (FGF) at 10, 20, and 30 ng/ml concentrations and found that 30 ng/ml of FGF in an ASXL3 -/- promoted neuronal cell differentiation similar to ASXL3 +/+ in 92% of our cells and may alleviate the effects of NDDs.
Awards (2)
- First Award of $5,000 $5,000
- Qatar Research, Development, and Innovation Council: The Qatar Research, Development, and Innovation Counil awards will recognize 10 projects in the following categories: • Agriculture and Water Management • Personalized Healthcare • Climate and Sustainability • Emerging Information Technologies
Competition history
- ISEF 2024
Resources
Related projects
ISEF · 2025
Decoding ASXL3: A Novel Predictor of the Spectrum, Onset, and Treatment for Neurodevelopmental Disorders
ISEF · 2023
SOX7: Novel Autistic Gene Identified Through Analysis of Multiomics and Human Brain Organoids
ISEF · 2017
Autism and Genetics: Understanding the Role of AUTS2 in the Pathology of Autism Spectrum Disorder
ISEF · 2016
Autism and Neurodegeneration: Linking Copy Number Variations in Genomic Regions of Autism to Neurological Disease
Closest projects by meaning, across every fair and year in the corpus.
Source: Regeneron International Science and Engineering Fair